Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125827701 | 12582770 | 1 | I | 20160708 | 20160722 | 20160722 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120410 | RANBAXY | DESHIMARU R, FUKUNAGA T, SATO T, MORINAGA S, TAKAHASHI M. A CASE OF METASTATIC FEMALE ADNEXAL TUMOR OF PROBABLE WOLFFIAN ORIGIN. GYNECOLOGIC ONCOLOGY REPORTS. 2014;10:22-24 | 30.00 | YR | F | Y | 0.00000 | 20160722 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125827701 | 12582770 | 1 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125827701 | 12582770 | 2 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK | U | U | 77926 | ||||||||
| 125827701 | 12582770 | 3 | SS | Medroxyprogesterone | MEDROXYPROGESTERONE | 1 | Oral | 400 MG, DAILY | U | 0 | 400 | MG | |||||||
| 125827701 | 12582770 | 4 | SS | Doxorubicin | DOXORUBICIN | 1 | Unknown | 50 MG/M2, EVERY 4 WEEKS, 3 CYCLES TAKEN | U | U | 0 | 50 | MG/M**2 | ||||||
| 125827701 | 12582770 | 5 | SS | Irinotecan | IRINOTECAN | 1 | Unknown | 50 MG/M2, ON DAYS 1 AND 8 OF A 28-DAY CYCLE FOR THREE CYCLES | U | U | 0 | 50 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125827701 | 12582770 | 1 | Uterine cancer |
| 125827701 | 12582770 | 2 | Uterine cancer |
| 125827701 | 12582770 | 3 | Uterine cancer |
| 125827701 | 12582770 | 4 | Uterine cancer |
| 125827701 | 12582770 | 5 | Uterine cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125827701 | 12582770 | DE |
| 125827701 | 12582770 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125827701 | 12582770 | Disease progression | |
| 125827701 | 12582770 | Drug hypersensitivity | |
| 125827701 | 12582770 | Interstitial lung disease | |
| 125827701 | 12582770 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |